- Third quarter revenue increased 233% compared to the same period last year; the sales forecast for the 2026 financial year has been raised
- Expanding industry leadership in fault tolerance with two consecutive world records that confirm the most credible path to universal, fault-tolerant quantum computing
- Announcement of the “Nexus” roadmap under “Apollo”; platform adoption increased nearly 20% quarter-on-quarter, and the number of orders submitted increased tenfold compared to the same period last year for the twelve months ending August 2026
- Signed the largest cloud contract in company history, including multi-year, guaranteed full-stack access via Apollo
- Expanding enterprise reach through an agreement with a leading hyperscaler and the launch of Oracle beta
/PRNewswire/ — – Quantinuum Inc. (Nasdaq: QNT) (the “Company”), a leading full-stack quantum computing company, today announced financial results for the third quarter ended September 30, 2026.
“In the third quarter, we expanded our technology leadership in the critical area of fault tolerance, expanded our customer base and expanded our routes to market,” said Rajeeb Hazra, President and Chief Executive Officer of Quantinuum. “This accelerated momentum underpins our increased revenue outlook for 2026 and strengthens our confidence in the opportunities ahead more than ever.”
Financial highlights of the third quarter of 2026
- Revenue was $9.1 million, up 233% from the same period last year, which brought in $2.7 million.
- GAAP gross margin was 33.3%, compared to (43.5%) in the prior year period.
- Adjusted gross margin was 74.6%, an increase of 853 basis points compared to the same period last year.
- Adjusted EBITDA loss was $80 million, compared to a loss of $45 million in the year-ago period.
- GAAP net loss was $118 million, compared to a net loss of $52 million in the year-ago period.
- GAAP net loss per share attributable to holders of Class A common stock was $0.46.
- Adjusted net loss per share was $0.29.
- Cash and cash equivalents as of September 30, 2026 were $1.94 billion.
Adjusted EBITDA, adjusted gross margin and adjusted net loss per share are non-GAAP financial measures defined under “Non-GAAP Financial Measures.” For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures, see the tables in the appendix at the end of this press release.
Third quarter and recent business highlights
Commercial highlights:
- Signed the largest cloud contract in company history, securing a multi-year contract extension with a leading global financial institution that includes guaranteed access through Apollo and Nexus.
- Signed an agreement with another of the world’s top five pharmaceutical companies to use quantum computing and AI in materials for cancer therapy, offering the potential to accelerate drug development and enable more effective treatments.
- Signed an agreement with GE Vernova to promote application development in the field of superconducting materials.
- Signing of an agreement with Abu Dhabi Maritime Academy and Quincus for research and applications in maritime logistics.
- Expanding cloud sales through a new agreement with a leading hyperscaler serving millions of developers, and expanding its partnership with Oracle by launching a joint beta program for hybrid quantum AI applications.
- Deepening commitment to the U.S. Government through continued implementation of the DARPA-QBI Phase B contract, active discussions on the scope of work for Phase C, and participation in four successful bids as part of Phase 1 of the Department of Energy’s Genesis Mission.
- International implementations have progressed: assembly of Helios in Singapore is already underway ahead of commissioning in spring 2027, and a system upgrade by Reimei at RIKEN in Japan is scheduled to be completed this month.
Product technology and supply chain:
- The company’s leading path toward universal, fully fault-tolerant quantum computing by 2029 has been validated by two consecutive world records in accuracy on Helios, using two codes within the same scalable, end-to-end end-to-end logic architecture. In October, a logical accuracy of 99.9995% was achieved – within Apollo’s target range – with an error rate 10 times lower than the September record and 100 times lower than the best published result in other hardware modalities. The results also demonstrate Quantinuum’s significant overhead and scalability advantage.
- Sol remains on schedule for the second half of 2027, with full-scale control system validation completed and integration and assembly targeted for the first quarter of 2027 – ahead of validation and tuning to 100 logical qubits at a target logical error rate of 10⁻⁵.
- Apollo remains on schedule for 2029, supported by design milestones including confirmation that our cryogenic system can be deployed at the required scale.
- The manufacturing foundation for future systems was strengthened through partnerships with GlobalFoundries, Infineon, Honeywell Aerospace and Monarch Quantum, and the CHIPS R&D grant was finally approved as the only company selected in the ion trap technology area.
Software:
- A cross-generation Nexus roadmap has been announced under Apollo, aligning application development and hybrid deployment across successive generations of hardware to create what the company believes will be the first developer platform designed for the era of fault tolerance.
- Expansion of fault-tolerant features with a September Nexus release that expands Guppy’s tools for programming logical qubits and support for error-correcting encodings, reducing the need to rewrite applications for specific codes. The release, scheduled for December, will expand responsive hybrid quantum-classical workflows, supported error-correcting codes, and execution analysis for application optimization.
- Nexus adoption and usage accelerated, with user numbers increasing nearly 20% quarter-over-quarter to 215 organizations; the total number of orders submitted increased tenfold in the 12 months to August 2026 compared to the previous 12-month period.
Ecosystem:
- Launched QUOPS with Sandia National Laboratories and NVIDIA to benchmark useful computing capabilities and speeds. Quantinuum drives industry-wide alignment to a common standard that supports customer comparisons and purchasing decisions.
- The ecosystem of quantum users expanded: Q-Net grew to over 800 members, eight start-up partners were added, and a global quantum competition was organized in collaboration with the National Quantum Office in Singapore, attracting more than 200 submissions.
Financial outlook
- Full-year 2026 revenue guidance is raised to $31 million to $34 million from $28 million to $32 million previously.
Third quarter 2026 conference call
Quantinuum will host a conference call on Thursday, November 5, 2026, at 5:00 p.m. Eastern Time to discuss results for the third quarter ended September 30, 2026. The conference call can be viewed live via webcast here.
A recording of the webcast will be made available on Quantinuum’s investor relations website following the conference call and will remain available there for one year.
Non-GAAP Financial Measures
To supplement Quantinuum’s condensed consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), the Company uses the following non-GAAP financial measures presented in this press release: adjusted gross profit, adjusted gross margin, adjusted net loss (fully distributed), adjusted EBITDA and adjusted net loss per share (fully distributed).
The adjusted gross profitis based on GAAP gross profit, with stock-based compensation attributable to cost of sales and associated employer taxes as well as depreciation and amortization attributable to cost of sales added back.
Die adjusted gross marginis calculated as adjusted gross profit divided by net sales.
The adjusted net loss, fully distributedassumes GAAP net loss on a converted basis and excludes stock-based compensation and related employer taxes, initial public offering and transition to public reporting costs, severance expense, the change in fair value of warrants classified as liabilities, and losses on the sale and depreciation of assets, and then applies an assumed statutory tax rate to the resulting adjusted pretax loss. No tax benefit is recognized for losses for which a full allowance has been made; Accordingly, no tax benefit is shown in the periods presented.
The adjusted EBITDA assumes adjusted net loss, fully distributed, and also excludes income tax expense, net interest income, and depreciation and amortization on acquired intangible assets.
The adjusted net loss per share (fully distributed)is calculated as the adjusted net loss (fully distributed) divided by the adjusted number of shares (fully distributed), both basic and diluted, consisting of the weighted average of the outstanding shares of Class A common stock and the common shares of Quantinuum Holdings.
Management believes that these measures provide investors with additional information useful in assessing the Company’s operating performance and developments over various time periods. Quantinuum’s results include significant non-cash expenses that management believes are not indicative of ongoing operating performance; This primarily involves share-based compensation recognized upon completion of the restructuring and the revaluation of warrants classified as liabilities. Both are driven by accounting triggers and external factors rather than operations. Because Quantinuum is an early commercial stage company, its results from period to period are also influenced by the timing of individual contracts. Metrics that separate underlying operating performance from non-cash and transitional items help investors assess trends over different time periods.
Due to Quantinuum’s “Up-C” structure, the GAAP net loss attributable to Quantinuum Inc. reflects only the Class A shares’ share of economic results. The presentation of the adjusted results on a converted, fully distributed basis provides a comprehensive picture of the company’s overall economic performance; On this basis, management evaluates the company’s performance and manages the company. Company management uses these key figures for internal planning and forecasting, to evaluate operational performance and to create budgets.
These non-GAAP financial measures are supplementary and have not been prepared in accordance with GAAP. It is not intended to be considered in isolation or as a substitute for the most comparable financial information prepared in accordance with United States GAAP. Quantinuum’s non-GAAP measures may differ from similar measures used by other companies and therefore may not be comparable. Investors should review the reconciliations and not rely on any single financial measure when assessing the company’s operations.
Each non-GAAP financial measure is compared to the most directly comparable GAAP financial measure in the tables at the end of this press release.
Information about Quantinuum
Quantinuum is a leader in quantum computing, offering a full-stack platform designed to make quantum computing viable in real-world environments. The company has commercially deployed multiple generations of trapped ion-based quantum systems based on its proven QCCD architecture, which it has implemented with novel designs and features to achieve the industry’s highest accuracy levels as measured by average two-qubit gate fidelity. Quantinuum has active collaborations with market leaders in pharmaceutical, materials science and financial services, government and industrial markets, as well as with academic and research institutions worldwide.
The company employs more than 850 people worldwide, including leading scientists and researchers. More than 70% of the technology team have a doctorate or master’s degree. Quantinuum is headquartered in Broomfield, Colorado, with additional locations in the United States, United Kingdom, Germany, Japan, Qatar and Singapore.
Availability of information on Quantinuum’s website
Investors and other interested parties should note that Quantinuum regularly discloses material information to investors and the market through SEC filings, press releases, public conference calls, webcasts and Quantinuum’s investor relations website. While not all information published by the Company on Quantinuum’s investor relations website is material, some information may be considered material. Accordingly, the Company recommends that investors, the media and anyone else interested in Quantinuum review the information published on ir.quantinuum.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the current beliefs and expectations of Quantinuum’s management and are subject to significant risks and uncertainties. Actual results may differ materially from those described in the forward-looking statements. All statements contained in this press release that are not historical facts, including statements regarding our beliefs, expectations and prospects, are forward-looking statements. Forward-looking statements include information about possible or anticipated future business results, including our forecasts and descriptions of our business plans and strategies. These statements often contain terms such as “anticipate,” “expect,” “forecast,” “indicate,” “plan,” “believe,” “intend,” “estimate,” “goal,” “forecast,” “should,” “could,” “would,” “may,” “will,” “forecast,” “outlook,” “potential,” “continue,” “seek,” “predict,” or the negative of these terms and other similar terms Expressions.
Factors that could cause actual results to differ materially from those described in the forward-looking statements include, but are not limited to: our ability to develop, commercialize and achieve market acceptance of our quantum computing hardware and software products; the pace of development of the quantum computing industry and the timing at which commercial quantum advantage will emerge; our ability to attract and retain customers for our quantum computing systems and our Quantum Computing as a Service offerings; the risk of technological obsolescence or the emergence of competing approaches to quantum computing, including superconducting, photonic or other techniques; our dependence on key suppliers and manufacturers of specialized components, including those required for our ion trap quantum systems; our ability to scale production of our quantum computers and related systems; our ability to protect our intellectual property and proprietary technology; the significant research and development costs associated with developing next-generation quantum computing capabilities; our ability to attract and retain highly qualified scientists, engineers and other personnel in a competitive labor market; changes in government funding, export controls or regulations affecting quantum technologies; uncertainties regarding the timing and scope of commercial applications; cybersecurity risks and the protection of sensitive customer data; and macroeconomic conditions, geopolitical instability and their potential impact on our business and operations. For further information about these and other risks that could affect the Company’s forward-looking statements, see the Company’s risk factors discussed in its filings with the Securities and Exchange Commission, including its most recent Quarterly Report on Form 10-Q, as these risk factors may be updated from time to time. You should evaluate all forward-looking statements contained in this press release in light of these risks and uncertainties. The Company disclaims any intention or obligation to update, revise or withdraw any forward-looking statements contained in this press release, except as required by applicable laws or regulations.
Contact
Contact person for investors and media
Shub Mukherjee – contact person for investors – [emailprotected]
Aaron Sorenson – Media Contact – [emailprotected]
Attachment
|
Condensed consolidated income statement (unaudited) |
|||||
|
(in thousands of dollars, except shares and per share data) |
|||||
|
Amounts may not add up due to rounding. |
Three months until September 30th |
Nine months until September 30th |
|||
|
2026 |
2025 |
2026 |
2025 |
||
|
Sales – net |
9,050 |
2,715 |
22,285 |
23,908 |
|
|
Costs and expenses: |
|||||
|
Cost of sales |
3,194 |
1,058 |
14,618 |
3,728 |
|
|
Depreciation expense |
4,184 |
2,839 |
12,554 |
8,517 |
|
|
Research and development costs – net |
97,482 |
42,382 |
519,433 |
117,822 |
|
|
Sales and marketing costs |
14,856 |
3,977 |
57,920 |
10,779 |
|
|
General and administrative costs |
22,149 |
5,334 |
182,752 |
16,903 |
|
|
Total costs and expenses |
141,865 |
55,590 |
787,277 |
157,749 |
|
|
Loss from operating business |
(132,815) |
(52,875) |
(764,992) |
(133,841) |
|
|
Interest income – net |
(14,324) |
(3,072) |
(23,807) |
(5,415) |
|
|
Loss from the change in the fair value of the warrant |
— |
2,100 |
111,815 |
9,900 |
|
|
Other (income)/expenses – net |
(283) |
3 |
(2,296) |
803 |
|
|
Loss before taxes |
(118,208) |
(51,906) |
(850,704) |
(139,129) |
|
|
Tax income/expense |
(357) |
130 |
260 |
313 |
|
|
Net loss |
(117,851) |
(52,036) |
(850,964) |
(139,442) |
|
|
Minus: Quantinum |
— |
n.z. |
(246,680) |
n.z. |
|
|
Minus: Not that one |
(100,899) |
n.z. |
(521,914) |
n.z. |
|
|
Net loss attributable to Quantinuum Inc |
(16,952) |
n.z. |
(82,370) |
n.z. |
|
|
Net loss per share attributable to holders of Class A common stock |
(0.46) |
n.z. |
(2.27) |
n.z. |
|
|
Weighted average number of shares to calculate the amount owed to holders |
36,806,913 |
n.z. |
36,216,440 |
n.z. |
|
|
(1) For the nine months ended September 30, 2026, the net loss per A common share and the weighted average number of A common shares for the period during the transactions ending September 30, 2026 are reported; which is the period beginning and following the effective date of the Transactions, as defined in Note 1 – “Description of Organization” – in Form 10-Q dated June 30, 2026. |
|||||
|
Condensed consolidated balance sheets (unaudited) |
||
|
(in thousands of dollars) |
||
|
30. September 2026 |
December 31, 2025 |
|
|
Assets |
||
|
Current assets: |
||
|
Cash and cash equivalents |
1,936,114 |
762,642 |
|
Debtors |
3,254 |
5,068 |
|
Claims against related parties |
336 |
604 |
|
Vorräte |
8,057 |
— |
|
Net investments in leasing, current |
5,773 |
5,773 |
|
Other current assets |
39,894 |
27,754 |
|
Total current assets |
1,993,428 |
801,841 |
|
Sachanlagen – netto |
162,598 |
120,965 |
|
Rights of use |
30,171 |
10,000 |
|
Goodwill |
771,506 |
784,822 |
|
Other intangible assets – net |
101,027 |
114,282 |
|
Net investments in leasing contracts, long-term |
5,773 |
10,102 |
|
Other assets – net |
20,373 |
3,613 |
|
Total assets |
3,084,876 |
1,845,625 |
|
liabilities |
||
|
Current liabilities: |
||
|
liabilities |
19,478 |
10,620 |
|
Due to relationships with close people |
— |
1,273 |
|
Deferred liabilities |
60,475 |
44,358 |
|
Total current liabilities |
79,953 |
56,251 |
|
Liability from the guarantee statement |
— |
38,400 |
|
Royalties payable, long-term portion |
55,345 |
55,345 |
|
Liabilities from operating leases, long-term |
29,137 |
7,143 |
|
Other liabilities |
605 |
893 |
|
Preliminary equity |
||
|
Series A Convertible Redeemable Preferred Stock, par value $0.0001 per share; 31,983,034 approved |
— |
288,129 |
|
Series A-1 Convertible Redeemable Preferred Stock, par value $0.0001 per share; 28,016,966 |
— |
400,978 |
|
Series B Convertible Redeemable Preferred Stock, par value $0.0001 per share; 31,753,266 approved |
— |
824,834 |
|
Equity / Equity of Quantinuum (Cayman) |
||
|
Quantinuum (Cayman) share capital |
— |
173,652 |
|
Preferred stock, par value $0.0001 per share; 20,000,000 shares authorized |
— |
— |
|
Class A common stock, par value $0.0001 per share; 2,000,000,000 authorized shares for |
4 |
— |
|
Class B common stock, par value $0.0001 per share; 2,000,000,000 shares authorized as of December 30th |
22 |
— |
|
Class A common stock, at cost; 72,863 shares or 0 shares as of |
(3,803) |
— |
|
Additional paid-up capital |
541,704 |
— |
|
Cumulative other comprehensive income (loss) |
(1,466) |
— |
|
Accumulated deficit |
(82,370) |
— |
|
Total capital attributable to Quantinuum Inc. / Quantinuum (Cayman). |
454,091 |
173,652 |
|
Minority shares |
2,465,745 |
— |
|
Total equity |
2,919,836 |
173,652 |
|
Total liabilities and equity |
3,084,876 |
1,845,625 |
|
Condensed consolidated cash flow statement (unaudited) |
||
|
(in thousands of dollars) |
||
|
Amounts may not add up due to rounding. |
Nine months until September 30th |
|
|
2026 |
2025 |
|
|
Cash flow from operating activities: |
||
|
Net loss |
(850,964) |
(139,442) |
|
Adjustments for reconciliation to net cash flow from operating activities |
||
|
Depreciation and amortization |
27,868 |
22,442 |
|
Non-cash leasing expense |
4,510 |
1,799 |
|
Revenue from leasing contracts with a put option |
— |
(16,526) |
|
Stock-based compensation expense |
484,699 |
— |
|
Loss from change in fair value of warrant liabilities |
111,815 |
9,900 |
|
(Gain)/loss from sale and impairment of assets |
(4) |
909 |
|
Interest expense |
5 |
6 |
|
Exchange rate gains/losses – net |
(118) |
(8) |
|
Access to quantum computing hardware |
6,889 |
4,746 |
|
Changes in operating assets and liabilities |
||
|
Debtors |
1,804 |
1,769 |
|
Claims against related parties |
224 |
424 |
|
Other current assets |
(20,836) |
(1,064) |
|
Net investment in leasing contracts |
4,330 |
4,330 |
|
Other assets – net |
(16,100) |
926 |
|
liabilities |
4,864 |
5,718 |
|
Due to relationships with close people |
(1,126) |
76 |
|
Deferred liabilities |
12,481 |
7,052 |
|
Other liabilities |
(253) |
84 |
|
Net cash outflow from operating activities |
(229,912) |
(96,859) |
|
Cash flow from investing activities: |
||
|
Capital expenditure |
(64,705) |
(61,021) |
|
Net cash outflow from investing activities |
(64,705) |
(61,021) |
|
Cash flow from financing activities: |
||
|
Proceeds from the issuance of preferred stock to Honeywell |
— |
350,000 |
|
Proceeds from the issuance of Series B Convertible Preferred Stock, less issuance costs |
— |
251,103 |
|
Proceeds from the issuance of common shares |
1,628,774 |
— |
|
Costs of issuing common shares |
(28,844) |
— |
|
Other issuing costs |
(814) |
|
|
Withholding taxes paid on stock compensation |
(130,780) |
— |
|
Net cash flow from financing activities |
1,468,336 |
601,103 |
|
Effects of Exchange Rate Changes on Cash and Cash Equivalents |
(247) |
1,589 |
|
Net increase in liquid assets |
1,173,472 |
444,812 |
|
Cash and cash equivalents at the beginning of the period |
762,642 |
172,343 |
|
Cash and cash equivalents at the end of the reporting period |
1,936,114 |
617,155 |
|
Non-cash investing and financing activities: |
||
|
Unpaid purchases of tangible assets |
9,094 |
3,913 |
|
Unpaid other exhibition costs |
1,774 |
7,263 |
|
Value of shares issued through the cashless exercise of warrants |
150,215 |
— |
|
Reconciliation from GAAP gross profit to adjusted gross profit (unaudited) |
|||||||
|
(in thousands of dollars, except for percentages) |
|||||||
|
Amounts may not add up due to rounding. |
Three months until September 30th |
Nine months until September 30th |
|||||
|
2026 |
2025 |
2026 |
2025 |
||||
|
Sales revenue, net |
9,050 |
2,715 |
22,285 |
23,908 |
|||
|
Cost of sales |
3,194 |
1,058 |
14,618 |
3,728 |
|||
|
Amortization of acquired intangible assets, share of cost of sales¹ |
2,839 |
2,839 |
8,518 |
8,517 |
|||
|
GAAP gross profit |
3,017 |
(1,182) |
(851) |
11,663 |
|||
|
GAAP Gross Margin |
33,3% |
(43,5%) |
(3,8%) |
48,8% |
|||
|
Share-based compensation and associated employer contributions² |
748 |
— |
7,321 |
— |
|||
|
Depreciation³ |
2,985 |
2,975 |
10,024 |
9,553 |
|||
|
Adjusted gross profit |
6,750 |
1,793 |
16,494 |
21,216 |
|||
|
Adjusted gross margin |
74,6% |
66,1% |
74,0% |
88,7% |
|||
|
(1) In our condensed consolidated statements of operations, amortization of acquired intangible assets is reported as a separate line and no subtotal is provided for gross profit. The amount shown in this table corresponds to the part of this line that is attributable to cost of sales and has been allocated accordingly to the assets to which it relates. The cost of sales is shown at the stated amount. The remaining share is reported under “Research and Development”. (2) Refers to expenses for share-based compensation and the associated employer contributions when equity shares vest, which are to be allocated to the cost of sales. Employer payroll taxes were 2 and 244 for the three and nine months ended September 30, 2026, respectively, and were 0 for the corresponding prior year periods. These amounts are part of the adjustment for stock-based compensation and related employer payroll taxes reflected in the reconciliation to GAAP net loss. (3) Refers to depreciation of property, plant and equipment and depreciation of acquired intangible assets, which are attributable to cost of sales. |
|||||||
|
Reconciliation of GAAP Net Loss to Adjusted Net Loss, Adjusted EBITDA and Adjusted Earnings Per Share (unaudited) |
||||
|
(in thousands of dollars, except for shares and per share amounts) |
||||
|
Amounts may not add up due to rounding. |
Three months until September 30th |
Nine months until September 30th |
||
|
2026 |
2025 |
2026 |
2025 |
|
|
counter |
||||
|
Net loss attributable to Quantinuum Inc |
(16,952) |
n.z. |
(82,370) |
n.z. |
|
Net loss attributable to Quantinuum (Cayman) before the transactions |
— |
n.z. |
(246,680) |
n.z. |
|
Net loss attributable to minority interests |
(100,899) |
n.z. |
(521,914) |
n.z. |
|
GAAP net loss, converted¹ |
(117,851) |
(52,036) |
(850,964) |
(139,442) |
|
Share-based compensation and associated employer contributions² |
37,333 |
— |
501,920 |
— |
|
Costs for the IPO and preparation for the listing as well as legal and other transaction costs³ |
4,937 |
— |
24,738 |
— |
|
Severance payments |
353 |
— |
353 |
— |
|
Adjustment of the fair value of warrants⁴ |
— |
2,100 |
111,815 |
9,900 |
|
Loss on sale and impairment of assets |
6 |
8 |
(4) |
909 |
|
Adjusted net loss, fully distributed |
(75,222) |
(49,928) |
(212,142) |
(128,633) |
|
Income tax expense (income) |
(357) |
130 |
260 |
313 |
|
Interest income, net |
(14,324) |
(3,072) |
(23,807) |
(5,415) |
|
Depreciation and other⁵ |
5,224 |
4,751 |
15,314 |
13,925 |
|
Amortization of acquired intangible assets⁶ |
4,184 |
2,839 |
12,554 |
8,517 |
|
Adjusted EBITDA |
(80,495) |
(45,280) |
(207,821) |
(111,293) |
|
denominator⁷ |
||||
|
Weighted average number of shares of Class A common stock outstanding, basic and diluted |
36,806,913 |
n.z. |
36,216,440 |
n.z. |
|
Common shares of Quantinuum Holdings |
225,242,666 |
n.z. |
226,892,141 |
n.z. |
|
Adjusted shares, fully distributed, basic and diluted |
262,049,579 |
n.z. |
263,108,581 |
n.z. |
|
Per share⁸ |
||||
|
GAAP net loss per share of Class A common stock, basic and diluted |
(0.46) |
n.z. |
(2.27) |
n.z. |
|
Adjusted net loss per share, fully distributed, basic and diluted |
(0.29) |
n.m. |
(0.81) |
n.m. |
|
(1) The converted basis includes the economic interests represented by shares of Class A common stock and shares of Quantinuum Holdings common stock as if all shares of common stock had been exchanged for shares of Class A common stock. This calculation is used because the Class A common stock represents only a minority ownership interest in Quantinuum Holdings. (2) Relates to non-cash compensation expense related to stock-based compensation, including expenses recognized in connection with the restructuring and related employer payroll taxes upon the exercise of stock options. Employer payroll taxes were $94 and $17,221 for the three and nine months ended September 30, 2026, respectively, and were zero for the corresponding prior year periods. The stock-based compensation component is consistent with the stock-based compensation expense item in the condensed consolidated statements of cash flows. (3) Refers to the costs of the IPO, transaction costs and the transition to reporting as a listed company. These costs are fees for consulting, legal, accounting, valuation and other professional or advisory services incurred in connection with the IPO. The extent of these costs is determined based on the reason and they are limited in time. They do not include the ongoing costs of operating as a listed company. (4) Refers to the non-cash change in fair value of warrants classified as liabilities that is attributable to valuation bases and accounting revaluations rather than to operational activities. (5) Refers to total depreciation and amortization as reflected in our condensed consolidated statement of cash flows, less amortization of acquired intangible assets, which are presented separately below. Includes depreciation on activated software. (6) Represents total amortization of acquired intangible assets for the period and is consistent with the depreciation expense item in the condensed consolidated statements of operations. (7) The denominator includes Class A common stock and all common shares of Quantinuum Holdings. Class B common shares are non-economic, carry voting rights only and are canceled upon conversion of the corresponding common shares. (8) GAAP net loss per share of Class A common stock relates only to the period beginning June 5, 2026 following the Transactions, while adjusted net loss per share, fully allocated, covers the entire nine-month period presented. The two metrics are therefore not calculated based on the same time period. No amounts per share are reported for periods before the restructuring, as the calculation would not produce any meaningful values for the recipients. |
||||